Patient safety stands at the forefront of the pharmaceutical industry's priorities. In the United States, legislative initiatives like the Drug Supply Chain Security Act (DSCSA) have been enacted to bolster supply chain security, emphasizing the need for innovative solutions to combat counterfeit pharmaceutical products.
